Chison Medical Technologies Co., Ltd. (688358.SS)
CNY 29.26
(1.95%)
CNY 29.26
(1.95%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 146.48 Million CNY | 38.39% |
| 2022 | 105.84 Million CNY | -5.89% |
| 2021 | 112.47 Million CNY | 12.88% |
| 2020 | 99.63 Million CNY | -5.23% |
| 2019 | 105.13 Million CNY | 10.59% |
| 2018 | 95.06 Million CNY | 48.44% |
| 2017 | 64.04 Million CNY | 110.21% |
| 2016 | 30.46 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 17.06 Million CNY | -52.34% |
| 2024 Q1 | 45.53 Million CNY | 802.04% |
| 2024 Q2 | 35.8 Million CNY | -21.38% |
| 2023 Q2 | 59.45 Million CNY | 13.21% |
| 2023 FY | 146.48 Million CNY | 38.39% |
| 2023 Q4 | 5.04 Million CNY | -82.87% |
| 2023 Q1 | 52.51 Million CNY | 365.8% |
| 2023 Q3 | 29.46 Million CNY | -50.43% |
| 2022 Q1 | 24.85 Million CNY | -28.38% |
| 2022 Q4 | -19.75 Million CNY | -139.62% |
| 2022 Q2 | 50.88 Million CNY | 104.75% |
| 2022 FY | 105.84 Million CNY | -5.89% |
| 2022 Q3 | 49.86 Million CNY | -2.0% |
| 2021 FY | 112.47 Million CNY | 12.88% |
| 2021 Q4 | 34.69 Million CNY | 13.42% |
| 2021 Q3 | 30.59 Million CNY | 25.41% |
| 2021 Q1 | 22.78 Million CNY | -32.61% |
| 2021 Q2 | 24.39 Million CNY | 7.04% |
| 2020 FY | 99.63 Million CNY | -5.23% |
| 2020 Q3 | 26.64 Million CNY | 22.29% |
| 2020 Q2 | 21.78 Million CNY | 25.32% |
| 2020 Q1 | 17.38 Million CNY | -60.52% |
| 2020 Q4 | 33.81 Million CNY | 26.91% |
| 2019 FY | 105.13 Million CNY | 10.59% |
| 2019 Q4 | 44.03 Million CNY | 93.42% |
| 2019 Q3 | 22.76 Million CNY | -30.44% |
| 2019 Q2 | 32.73 Million CNY | 485.29% |
| 2019 Q1 | 5.59 Million CNY | -85.96% |
| 2018 FY | 95.06 Million CNY | 48.44% |
| 2018 Q4 | 39.83 Million CNY | 0.0% |
| 2017 FY | 64.04 Million CNY | 110.21% |
| 2016 FY | 30.46 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Shenzhen Lifotronic Technology Co., Ltd. | 328.57 Million CNY | 55.42% |